Net Revenue: 24.0 M€ EBITDA: 3.0 M€ Number of Employees: 700
The group was established in the 90 s with the registered office in China and is now developing into a leading pharmaceutical company in Asia with vertically integrated intermediates and formulations based on R & D manufacture and sales. As an innovative and dynamic group in pharmaceuticals the products mainly involve in Psychotropic Cardiovascular Antithrombotic Antitumor Gastrointestinal Anti-infection(antivirotic) and Veterinary. The Company s market covers Asia Europe Africa South Am
Listed by M&A World Support Center, M&A World Business Support Center on Friday, 03 March 2017 [Seller (Sell-side)] - Ref.: 62
4467 Hits